The Filing Desk

Axogen vs Establishment Labs Holdings

Axogen AXGN · Establishment Labs Holdings ESTA · Health Care Equipment

Axogen reported revenue of $225 million in fiscal 2025, about the same as Establishment Labs Holdings' $211 million in fiscal 2025. Axogen's revenue grew 20.2% in its latest year, and Establishment Labs Holdings' grew 27.1%. Axogen had an operating margin of -3.5%, against -18.5% at Establishment Labs Holdings. Free cash flow was −$3 million at Axogen and −$57 million at Establishment Labs Holdings.

Side by side

AxogenEstablishment Labs Holdings
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$225M$211M
Revenue growth20.2%27.1%
Revenue growth a year, last 5 years14.9%20.0%
Gross margin74.3%69.3%
Operating margin−3.5%−18.5%
Net margin−7.0%−24.2%
Free cash flow−$3M−$57M
Free cash flow margin−1.3%−27.0%
Return on capital−4.9%−39.0%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count4.0%5.2%
Last close$55.93$70.75
P/E at the last close——
Insider trades, last 12 monthssold $17.1 millionsold $35.5 million
Piotroski F-score5 of 93 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
AxogenEstablishment Labs Holdings
Operating margin
Percent of revenue
AxogenEstablishment Labs Holdings
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AxogenEstablishment Labs Holdings

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Axogen and Establishment Labs Holdings pages.